Uncertainty in Accounting Estimates Due to COVID-19
First written in FY2021-Q1. 2 of 6 entries say "Worsened", first in FY2021-Q2. Latest entry: FY2022-Q3.
The whole theme swung hardest in 2026: 3 of 7 companies on the "Worse" side.
33 other companies' latest entry also says "Restated".
- FY2022-Q3RestatedAnnual report
「There have been no material changes to the estimates or underlying assumptions concerning the impact of the spread of COVID-19 described in the additional information to the securities report for the previous consolidated fiscal year.」
The Company reconfirmed that there had been no material changes in the accounting estimates and assumptions concerning COVID-19. - FY2022-Q1RestatedAnnual report
「There have been no material changes to the estimates or underlying assumptions concerning the impact of the spread of COVID-19 described in the additional information to the securities report for the previous consolidated fiscal year.」
The Company reconfirmed that there had been no material changes from the previous consolidated fiscal year in the accounting estimates and assumptions concerning COVID-19. - FY2021MitigatedAnnual report
「The accounting treatment reflects the assumption that the business environment would remain unstable in the first half of fiscal 2021, while economic activity would gradually return to normal from the second half onward as vaccination became more widespread.」
The assumption changed from the previous quarters’ delayed recovery and continued unstable environment to an expectation of normalization driven by the spread of vaccines from the second half of fiscal 2021 onward. However, uncertainty and the potential impact on results remain. - FY2021-Q3WorsenedAnnual report
「In view of the above circumstances, the accounting treatment reflects the assumption that an unstable business environment resulting from the spread of COVID-19 would continue from the fourth quarter of the current consolidated fiscal year through the end of fiscal 2021, as in the current fiscal year.」
The accounting treatment reflects the assumption that an unstable business environment would continue from the fourth quarter through the end of fiscal 2021. Compared with the recovery timing assumed at the second-quarter stage, the Company expects the impact of the infection to continue for a longer period. - FY2021-Q2WorsenedAnnual report
「In view of the continuing global spread of COVID-19, the accounting treatment at the end of the second quarter of the current consolidated fiscal year reflects the assumption that the shift to a full-scale recovery trend would be postponed until fiscal 2021 or later.」
The timing of the shift to a full-scale recovery was pushed back to fiscal 2021 or later from the first-quarter assumption of a “gradual recovery from the second half of fiscal 2020 onward.” The uncertainty of the accounting estimates concerning the impact of the infection and its potential effects also continues to be disclosed. - FY2021-Q1First statedAnnual report
「The accounting treatment reflects the assumption that the impact of the spread of COVID-19 would gradually recover from the second half of fiscal 2020 onward. However, there have been no material changes to the assumptions underlying the estimates described in the additional information to the securities report for the previous consolidated fiscal year. The impact of the spread of COVID-19 remains subject to considerable uncertainty and may affect the financial position and operating results of the Group from the second quarter of the current consolidated fiscal year onward.」
In its accounting estimates, including impairment accounting for fixed assets and the recoverability of deferred tax assets, the Company assumed a gradual recovery from the second half of fiscal 2020 onward and disclosed the uncertainty surrounding the impact of the infection and its potential effects on future financial position and operating results.